OTC Denavir
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham expects its application to switch its penciclovir 1% drug for cold sores to over-the-counter status to be considered at a Dec. 1 joint meeting of FDA's NDAC and Antiviral Drugs Advisory Committee